Sarcoma

Adolescents and young adults with sarcoma prescribed opioids for pain often continued using those substances after treatment completion, according to study results published in Cancer.

Entrectinib demonstrated durable systemic and intracranial responses in patients with NTRK fusion-positive solid tumors, according to study results published in Clinical Cancer Research.

Use of proton beam therapy increased significantly among patients with cancer in the U.S. between 2004 and 2018, but Black individuals had a lower likelihood of receiving the therapy than their white counterparts.

James Amatruda, MD, PhD, never set out to become a fish farmer.

Fox Chase Cancer Center announced two faculty appointments.

Ripretinib did not extend PFS compared with sunitinib for patients with advanced gastrointestinal stromal tumor who previously received imatinib, according to randomized phase 3 study results presented during the ASCO Plenary Series.

The FDA granted rare pediatric disease designation to IMX-110 for treatment of children with rhabdomyosarcoma.

The FDA approved sirolimus protein-bound particles for injectable suspension (albumin-bound) for treatment of adults with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor.

Half of patients with relapsed or refractory solid tumors achieved objective response to an infusion of IMA203, according to study results presented at Society for the Immunotherapy of Cancer Annual Meeting.

Ripretinib failed to prolong PFS compared with sunitinib among patients with gastrointestinal stromal tumor who received prior treatment with imatinib, according to results of the phase 3 INTRIGUE study released by the agent’s manufacturer.